MedPath

An Assessment of the Occurrence of Hormone Deficiency in Patients With Empty Sella

Not Applicable
Conditions
Empty Sella
Interventions
Diagnostic Test: ITT
Registration Number
NCT04700020
Lead Sponsor
Universitair Ziekenhuis Brussel
Brief Summary

The goal of this prospective study is to analyse the hormonal components in the blood of patients that were diagnosed with empty sella. Hereby we only take the hormones into consideration that are produced by the pituitary gland and/or are influenced by it due to positive/negative feedback. These are GH, ACTH, TSH, FSH, LH, PRL, oxytocine, ADH but also IGF-1, estradiol, testosteron, F4 and cortisol. The purpose is to see if abnormalities of the blook levels can be explained by the absence/shrinking of the pituitary gland. During this study, there will be a blood draw twice. The reason is to avoid wrong positive and negative results. Together with the second blood draw, there will be an insuline tolerance test in all patients. MRI will only be done if the last taken image is more than two years old or if the MRI was not taken with main focus on the pituitary gland.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Patients that were diagnosed with an (partial) empty sella detected by MRI or CT of the brain have been included in this study. Whenever the MRI or CT scan was performed more than two years ago, a new MRI scan was required.
Exclusion Criteria
  • Children (patients less than 18 years) and patients with earlier diagnosed carcinomas of the brain as well as patients with secondary empty sella (antecedents of radiation, pharmacological treatment of pituitary adenomas, traumatic head injury and surgery of the pituitary gland as well as the central nervous system) were not included.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Patients above the age of 18 yearsITTIn the context of this study, we will take two blood samples. In addition to the second blood sample, an insulin tolerance test (ITT) is also performed, even if the result of the blood values is normal. MRI will only be performed if the previous imaging was done more than two years ago or when the quality of the MRI was not good enough to measure the volume of the pituitary gland.
Primary Outcome Measures
NameTimeMethod
The proportion of patients that have hormone deficiencyWithin two years after empty sella has been found on MRI or CT

The proportion of patients that have hormone deficiency when the condition "empty sella" is found on MRI or CT

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Universitair Ziekenhuis Brussel

🇧🇪

Brussels, Jette, Belgium

© Copyright 2025. All Rights Reserved by MedPath